English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Genome-edited CAR-T cell therapy shows early promise against aggressive childhood leukemia
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Study links genetic variation on chromosome 10 to specific eye deposits in macular degeneration
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

MIT study identifies early relapse marker predicting poor prognosis in aggressive T-cell lymphoma
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Meta-analysis finds laughing gas offers rapid but short-lived relief for depression
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Study suggests less toxic regimen effective for rare aggressive lymphoma
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Combination immunotherapy shows promise for aggressive lymphoma survival rates
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Industrial chemicals found to alter balance of human gut microbiome
+ Pharmaceuticals
Patient Daily | Dec 24, 2025

Lymphocyte counts may guide care after CAR T-cell therapy in non-Hodgkin lymphoma

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes